ПЕРВЫЙ ОПЫТ ПРИМЕНЕНИЯ ЛОКАЛЬНОЙ ГИПЕРТЕРМИИ В КОМБИНИРОВАННОМ ЛЕЧЕНИИ ОПЕРАБЕЛЬНОГО НЕМЕЛКОКЛЕТОЧНОГО РАКА ЛЕГКИХ

Добродеев Алексей Юрьевич, Завьялов Александр Александрович, Тузиков Сергей Александрович et al. · Siberian Journal of Oncology · 2015

The paper presents the first experience in treating 5 patients with stage II-III non-small cell lung cancer using combined modality treatment including 40 Gy preoperative hyperfractionated radiotherapy with concurrent 2 cycles of paclitaxel/carboplatin chemotherapy and local hyperthermia (10 sessions) followed by radical surgery. The overal response rate to preoperative treatment was 80 %. Chemotherapy was well tolerated and hyperthermia resulted no in adverse effects. All patients underwent surgery (4 lobectomies and 1 pneumonectomy). No complications were observed in the postoperative period. The follow-up period ranged from 6 to 20 months. No evidence of disease progression and radiation-induced damages were observed.

Cited by 0 works.

Authors